The potential benefits of rapid-acting insulin analogs versus regular human insulin are that the analogs have earlier onset and peak of biologic activity, resulting in lower postprandial glucose levels; a shorter duration of action, resulting in less late-prandial hypoglycemia; and less biologic variab...
Because it has no peak effect in and troughs drug concentration. Because of the and has a nearly 24-hour duration of action, the au- of complexity managing diabetes for some patients, thors concluded that glargine was a more optimal new methods to diabetes are al- insulin NP...
this is the key difference between NPH and regular insulin. Moreover, NPH has a slower onset phase but lasts for a longer period of time. Regular insulin has a rapid onset but wears off in shorter time periods. Besides
The potential benefits of rapid-acting insulin analogs versus regular human insulin are that the analogs have earlier onset and peak of biologic activity, resulting in lower postprandial glucose levels; a shorter duration of action, resulting in less late-prandial hypoglycemia; and less biologic variab...